title: Targeted Cancer Therapies World Congress 2010--part 1. 21-23 September 2010, Zurich, Switzerland.
abstract: The Targeted Cancer Therapies World Congress, held in Zurich, included topics covering new developments in the field of cancer therapy. This conference report highlights selected presentations on the global market for targeted cancer therapies, understanding European regulatory evaluation strategies and meeting the requirements for acceptable reimbursement.
authors.affiliation: ImClone Systems, Branchburg, 61 Imclone Drive, Branchburg, NJ 08853, USA. hagop.youssoufian@imclone.com
authors.forename: Hagop
authors.initials: H
authors.lastname: Youssoufian
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000191:economics / Q000494:pharmacology* / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics; D038622:Internationality; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents